Exabis Library
Welcome to the e-CCO Library!
P318: Safety of Biological Therapies in Elderly IBD: a Systematic Review and Meta-analysis
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P318: Ustekinumab: early experience and medium-term outcomes from a UK multi-centre real-world cohort
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P319 Clinical characteristics of patients with inflammatory bowel disease and metabolic syndrome
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P319: Accurate cut-offs for predicting endoscopic activity and mucosal healing in Crohn's disease with fecal calprotectin
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P319: Characteristics of filgotinib-treated patients with Ulcerative Colitis who achieve sustained corticosteroid-free remission: Post hoc analysis of the phase 2b/3 SELECTION study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P319: Combining anti-inflammatory treatment with antiviral treatment in severe cytomegalovirus-positive ulcerative colitis does not affect colectomy rate: a retrospective European multicentre study
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P319: Impact of biological agents on postoperative complications in inflammatory bowel disease: a multicentre study of GETECCU
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P319: Incorporating HLADQA1*05 in pre-biologic screening in IBD patients initiating biologic therapies
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P319: Long-term outcomes after anti-TNF therapy withdrawal in patients with radiologically healed perianal Crohn’s fistulas
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P319: Trough levels of adalimumab better correlate with combined mucosal and transmural healing than clinical remission in Korean patients with Crohn’s disease on adalimumab maintenance therapy
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P320 Thrombocytosis in acute inflammatory bowel disease: a useful biomarker?
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P320: 6-Thioguanine nucleotide levels are associated with trough levels of infliximab and adalimumab in Inflammatory Bowel Disease patients on combination therapy: A retrospective multicentre study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P320: Accuracy of faecal calprotectin level to select patients with inflammatory bowel disease for a chromoendoscopy surveillance programme
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P320: Clinical and economic effect of short infliximab infusion protocol in patients with inflammatory bowel diseases: a multicentre study
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P320: Combined mesenchymal stromal cells and anti-cytokine therapy of perianal Crohn's disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P320: Confocal Laser Endomicroscopy to predict the efficacy of vedolizumab as first-line biotherapy in ulcerative colitis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P320: High Cytomegalovirus DNA load in mucosal biopsies predicts steroid failure as well as colectomy in acute severe ulcerative colitis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P320: Utility of a semi-quantitative rapid test in diagnosis of ulcerative colitis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P321 Prognosis of intestinal Behcet’s disease according to the Korean consensus-based diagnostic algorithm
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P321: Activity graph patterns recorded using a mobile monitoring system are associated with clinical outcomes of patients with Crohn's disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM